CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
NCT05896124
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Primary Biliary Cholangitis (PBC)
Interventions
DRUG:
2mg CS0159
DRUG:
Placebo
Sponsor
Cascade Pharmaceuticals, Inc